Last 12 months
Inside the activity.
0 purchase rows · 58 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 8 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2020 Filed Aug 12, 2020 23:07 UTC |
SANQUINI RICHARD LDirector
|
SaleCommon Stock | 5,704 | $86.58 | $493,867.15 |
DisclosureSEC source: 0001209191-20-046468 · doc4.xml · nonDerivative · entry 1 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,349 F1 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated February 20, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.68, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 113 | $88.99 | $10,055.87 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 4 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,970 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 250 | $87.88 | $21,970.00 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,083 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.65 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 801 | $86.15 | $69,003.03 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,333 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.84 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 2,107 | $85.35 | $179,826.55 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,134 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC |
Chan NelsonDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · derivative · entry 6 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC |
Chan NelsonDirector
|
SaleCommon Stock | 419 | $88.99 | $37,286.81 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 5 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,743 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC |
Chan NelsonDirector
|
SaleCommon Stock | 1,850 | $87.87 | $162,553.03 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 4 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,162 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.55 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC |
Chan NelsonDirector
|
SaleCommon Stock | 8,013 | $86.12 | $690,092.38 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,012 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC |
Chan NelsonDirector
|
SaleCommon Stock | 18,968 | $85.46 | $1,620,982.52 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,025 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.80, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC |
Chan NelsonDirector
|
Exercise / conversionCommon Stock | 4,500 | $46.50 | $209,250.00 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:26 UTC |
Allgood Kiva A.Director
|
SaleCommon Stock | 300 | $88.99 | $26,697.00 |
DisclosureSEC source: 0001209191-20-046417 · doc4.xml · nonDerivative · entry 1 Allgood Kiva A. · CIK 0001778208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,859 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 298 | $0.00 Strike: $45.32 | $0.00 |
DisclosureSEC source: 0001209191-20-046414 · doc4.xml · derivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 298 shares Expires 2024-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable on August 4, 2018 following the vesting commencement date of August 4, 2017. The remaining 2/3rds vested quarterly until fully vested on August 4, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 298 | $88.99 | $26,519.02 |
DisclosureSEC source: 0001209191-20-046414 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionCommon Stock | 298 | $45.32 | $13,505.36 |
DisclosureSEC source: 0001209191-20-046414 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 22:24 UTC |
Geeslin KeithDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,013 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-046223 · doc4.xml · derivative · entry 6 GEESLIN KEITH · CIK 0001196198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,487 Underlying: Common Stock · 3,013 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant until fully vested on October 28, 2014. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 22:24 UTC |
Geeslin KeithDirector
|
SaleCommon Stock | 1,578 | $90.15 | $142,263.49 |
DisclosureSEC source: 0001209191-20-046223 · doc4.xml · nonDerivative · entry 3 GEESLIN KEITH · CIK 0001196198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,735 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.195, inclusive. The reporting person undertakes to provide to Synaptics Incorporated, (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 22:24 UTC |
Geeslin KeithDirector
|
Exercise / conversionCommon Stock | 3,013 | $46.50 | $140,104.50 |
DisclosureSEC source: 0001209191-20-046223 · doc4.xml · nonDerivative · entry 2 GEESLIN KEITH · CIK 0001196198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:36 UTC |
SANQUINI RICHARD LDirector
|
GrantCommon Stock | 188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-045990 · doc4.xml · nonDerivative · entry 1 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,053 F1 · price: The shares were issued to the reporting person representing a portion of the director's annual retainer fee. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 23:44 UTC |
Awsare SaleelSee Remarks
|
Tax withholdingCommon Stock | 865 | $80.02 | $69,217.30 |
DisclosureSEC source: 0001209191-20-044558 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,241 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:22 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $62.11 | $0.00 |
DisclosureSEC source: 0001209191-20-043507 · doc4.xml · derivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2021-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on each quarter following the October 24, 2014 date of grant, until fully vested on October 24, 2017. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:22 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 3,000 | $80.00 | $240,000.00 |
DisclosureSEC source: 0001209191-20-043507 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:22 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionCommon Stock | 3,000 | $62.11 | $186,315.00 |
DisclosureSEC source: 0001209191-20-043507 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 744 | $0.00 Strike: $61.40 | $0.00 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · derivative · entry 6 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires 2021-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 28, 2014 date of grant until fully vested on April 28, 2017. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 744 | $0.00 Strike: $60.22 | $0.00 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · derivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires 2021-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC |
NOLAN KERMITSee Remarks
|
SaleCommon Stock | 1,488 | $78.22 | $116,391.36 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,993 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC |
NOLAN KERMITSee Remarks
|
SaleCommon Stock | 4,000 | $80.00 | $320,000.00 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,481 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock | 744 | $61.40 | $45,681.60 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:02 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock | 744 | $60.22 | $44,803.68 |
DisclosureSEC source: 0001209191-20-043498 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:55 UTC |
Buchanan JeffreyDirector
|
SaleCommon Stock | 7,500 | $78.22 | $586,650.00 |
DisclosureSEC source: 0001209191-20-043494 · doc4.xml · nonDerivative · entry 1 BUCHANAN JEFFREY D · CIK 0001247555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,681 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 24, 2020. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:30 UTC |
SANQUINI RICHARD LDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,900 | $0.00 Strike: $52.57 | $0.00 |
DisclosureSEC source: 0001209191-20-035098 · doc4.xml · derivative · entry 6 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,900 shares Expires 2023-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2016 date of grant until fully vested on October 28, 2017. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:30 UTC |
SANQUINI RICHARD LDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,400 | $0.00 Strike: $62.11 | $0.00 |
DisclosureSEC source: 0001209191-20-035098 · doc4.xml · derivative · entry 5 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,400 shares Expires 2021-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12 of the total number of shares subject to the option vested and became exercisable on the 24th day of each month following the October 24, 2014 date of grant until fully vested on October 24, 2015. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:30 UTC |
SANQUINI RICHARD LDirector
|
SaleCommon Stock | 5,300 | $72.00 | $381,600.00 |
DisclosureSEC source: 0001209191-20-035098 · doc4.xml · nonDerivative · entry 3 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,865 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 19, 2020. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:30 UTC |
SANQUINI RICHARD LDirector
|
Exercise / conversionCommon Stock | 2,900 | $52.57 | $152,453.00 |
DisclosureSEC source: 0001209191-20-035098 · doc4.xml · nonDerivative · entry 2 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:30 UTC |
SANQUINI RICHARD LDirector
|
Exercise / conversionCommon Stock | 2,400 | $62.11 | $149,052.00 |
DisclosureSEC source: 0001209191-20-035098 · doc4.xml · nonDerivative · entry 1 SANQUINI RICHARD L · CIK 0001228342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.34 | $0.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · derivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the May 14, 2014 date of grant until fully vested on May 14, 2017. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 4,000 | $70.01 | $280,040.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 1,000 | $70.00 | $70,000.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionCommon Stock | 5,000 | $59.34 | $296,700.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:49 UTC |
Buchanan JeffreyDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,613 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-034160 · doc4.xml · derivative · entry 3 BUCHANAN JEFFREY D · CIK 0001247555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,613 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:49 UTC |
Buchanan JeffreyDirector
|
SaleCommon Stock | 2,613 | $65.00 | $169,845.00 |
DisclosureSEC source: 0001209191-20-034160 · doc4.xml · nonDerivative · entry 2 BUCHANAN JEFFREY D · CIK 0001247555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,181 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 24, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:49 UTC |
Buchanan JeffreyDirector
|
Exercise / conversionCommon Stock | 2,613 | $46.50 | $121,504.50 |
DisclosureSEC source: 0001209191-20-034160 · doc4.xml · nonDerivative · entry 1 BUCHANAN JEFFREY D · CIK 0001247555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:46 UTC |
Hardman SusanDirector
|
GrantCommon Stock | 1,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032169 · doc4.xml · nonDerivative · entry 1 HARDMAN SUSAN J · CIK 0001185652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,864 F1 · shares: 790 of the deferred stock units shall vest on July 31, 2020, and 1,074 of the deferred stock units shall vest on October 31, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:58 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 39 | $67.14 | $2,618.46 |
DisclosureSEC source: 0001209191-20-028983 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,106 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:58 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 1,384 | $66.34 | $91,816.22 |
DisclosureSEC source: 0001209191-20-028983 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,145 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.88, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:58 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 2,851 | $65.60 | $187,024.17 |
DisclosureSEC source: 0001209191-20-028983 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,529 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.99, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,277 | $0.00 Strike: $45.32 | $0.00 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · derivative · entry 5 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298 Underlying: Common Stock · 3,277 shares Expires 2024-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of August 4, 2017, with the remaining two-thirds vesting quarterly until fully vested on August 4, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 61 | $67.14 | $4,095.54 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F2 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 2,343 | $66.29 | $155,324.26 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,941 F2 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.99 to $66.86, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 4,251 | $65.59 | $278,827.77 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,284 F2 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.99 to $65.94, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.